oral medication glp 1 The Food and Drug Administration has approved the first GLP-1 weight loss drug by Eli Lilly, called Foundayo GLP-1 Agonists: A Comprehensive Overview

2015 Apr;30(5):606-9

Serious side effects of Bydureon BCise that have been reported include: gallbladder problems, including gallstones and inflammation (swelling) of your gallbladder kidney damage low platelet levels low blood sugar levels serious reactions at your injection site, including an abscess (a lump under the skin that contains pus) or necrosis (skin death) pancreatitis (inflammation of your pancreas)* boxed warning: risk of thyroid cancer* allergic reaction* * For more information about this side effect, see the Side effect focus section below

Initial loading phases build reserves, while maintenance phases sustain benefits

The role of exercise in modulating ferroptosis is summarized in Table 3